 |
0 Diseases |  |
42 Trials |
|
42 Trials |  |
2742 News |  |
| «12...34353637383940414243444546» |
- New trial: ADIC: Antibiotic Dosing in Pediatric Intensive Care (clinicaltrials.gov) - May 29, 2015
P=N/A, N=150, Recruiting, Sponsor: University Hospital, Ghent
- | amoxycillin/clavulanate / Generic mfg.
Trial initiation date, Trial primary completion date: AntibioCor: Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone (clinicaltrials.gov) - Apr 14, 2015
P3, N=280, Not yet recruiting, Sponsor: University Hospital, Lille
Initiation date: Jan 2015 --> May 2015 | Trial primary completion date: Jan 2017 --> May 2017
- amoxycillin/clavulanate / Generic mfg.
New P1 trial: Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers (clinicaltrials.gov) - Mar 20, 2015
P1, N=24, Recruiting, Sponsor: National University Hospital, Singapore
- Trial primary completion date: BISER: Bacteriology and Inflammation in Bronchiectasis (clinicaltrials.gov) - Mar 10, 2015
P=N/A, N=80, Recruiting, Sponsor: Guangzhou Institute of Respiratory Disease
Initiation date: Jan 2015 --> May 2015 | Trial primary completion date: Jan 2017 --> May 2017 Trial primary completion date: Sep 2013 --> Dec 2017
- amoxycillin/clavulanate / Generic mfg., cefadroxil / Generic mfg.
Biomarker, New P2 trial, Combination therapy: Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers (clinicaltrials.gov) - Mar 7, 2015
P2, N=28, Recruiting, Sponsor: National University Hospital, Singapore
- ||||||| Invanz (ertapenem) / Merck (MSD)
Trial completion: MOXIPEDIA: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection (clinicaltrials.gov) - Feb 19, 2015
P3, N=454, Completed, Sponsor: Bayer
Trial primary completion date: Sep 2013 --> Dec 2017 Active, not recruiting --> Completed
- | meropenem / Generic mfg.
New P2 trial: Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis (clinicaltrials.gov) - Jan 29, 2015
P2, N=46, Completed, Sponsor: Task Foundation NPC
- |||| Invanz (ertapenem) / Merck (MSD)
Trial primary completion date: MOXIPEDIA: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection (clinicaltrials.gov) - Jan 26, 2015
P3, N=454, Active, not recruiting, Sponsor: Bayer
Active, not recruiting --> Completed Trial primary completion date: Apr 2015 --> Jan 2015
- amoxycillin/clavulanate / Generic mfg.
Clinical: Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate (clinicaltrials.gov) - Jan 17, 2015
P=N/A, N=300, Recruiting, Sponsor: Albany Medical College
- ||||||| ceftriaxone / Generic mfg., ceftaroline fosamil / Generic mfg.
Trial completion: Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP) (clinicaltrials.gov) - Jan 13, 2015
P2/3, N=161, Completed, Sponsor: Cerexa, Inc.
Trial primary completion date: Apr 2015 --> Jan 2015 Active, not recruiting --> Completed
- | amoxycillin/clavulanate / Generic mfg.
Biomarker, Trial completion: A Clinical Study to Explore Biomarkers for Drug-induced Liver Injury (DILI) (clinicaltrials.gov) - Dec 24, 2014
P1, N=32, Completed, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- cefuroxime / Generic mfg., amoxycillin/clavulanate / Generic mfg.
Trial primary completion date: AMOCEF: Pharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care Units (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=60, Recruiting, Sponsor: University Hospital, Ghent
Recruiting --> Completed Trial primary completion date: May 2013 --> May 2015
- || amoxycillin/clavulanate / Generic mfg.
New P3 trial: AntibioCor: Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone (clinicaltrials.gov) - Nov 4, 2014
P3, N=280, Not yet recruiting, Sponsor: University Hospital, Lille
- ||| amoxycillin/clavulanate / Generic mfg.
Trial completion: Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota (clinicaltrials.gov) - Jul 24, 2014
P=N/A, N=53, Completed, Sponsor: Beth Israel Deaconess Medical Center
Trial primary completion date: May 2013 --> May 2015 Active, not recruiting --> Completed
- clindamycin phosphate / Generic mfg.
Clinical: Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction (clinicaltrials.gov) - Jul 23, 2014
P=N/A, N=100, Recruiting, Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- || amoxycillin/clavulanate / Generic mfg.
New P3 trial: ANTHARTIC: Antibiotherapy During Therapeutic Hypothermia to Prevent Infectious Complications (clinicaltrials.gov) - Jul 12, 2014
P3, N=192, Recruiting, Sponsor: University Hospital, Limoges
- Trial completion date, HEOR: Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life (clinicaltrials.gov) - May 28, 2014
P4, N=100, Active, not recruiting, Sponsor: University of Chicago
Active, not recruiting --> Completed Trial completion date: Dec 2009 --> Dec 2014
- amoxycillin/clavulanate / Generic mfg.
Biomarker, New P1 trial: A Clinical Study to Explore Biomarkers for Drug-induced Liver Injury (DILI) (clinicaltrials.gov) - May 19, 2014
P1, N=32, Recruiting, Sponsor: Seoul National University Hospital
- ||||| clindamycin phosphate / Generic mfg., amoxycillin/clavulanate / Generic mfg.
New P4 trial: AUGDENT: AUGMENTIN (clinicaltrials.gov) - May 15, 2014
P4, N=472, Completed, Sponsor: GlaxoSmithKline
- ||||| ceftriaxone / Generic mfg., ceftaroline fosamil / Generic mfg.
Enrollment closed: Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP) (clinicaltrials.gov) - Apr 15, 2014
P2/3, N=160, Active, not recruiting, Sponsor: Cerexa, Inc.
Trial completion date: Dec 2009 --> Dec 2014 Recruiting --> Active, not recruiting
- linezolid oral / Generic mfg.
Clinical data: PRESTO:Osteo: Patients Response to Early Switch To Oral:Osteomyelitis Study (clinicaltrials.gov) - Mar 26, 2014
P0, N=456, Not yet recruiting, Sponsor: Julio Ramirez
- ||||| Invanz (ertapenem) / Merck (MSD)
Enrollment closed: MOXIPEDIA: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection (clinicaltrials.gov) - Jan 27, 2014
P3, N=459, Active, not recruiting, Sponsor: Bayer
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Enrollment open: PREDICT: Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract (clinicaltrials.gov) - Jan 13, 2014
P3, N=436, Recruiting, Sponsor: Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- || New P3 trial: PREDICT: Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract (clinicaltrials.gov) - Dec 25, 2013
P3, N=436, Recruiting, Sponsor: Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
- New P3 trial: Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients (clinicaltrials.gov) - Dec 9, 2013
P3, N=16, Recruiting, Sponsor: Medical University of Vienna
- || amoxycillin/clavulanate / Generic mfg.
Trial completion: Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis (clinicaltrials.gov) - Nov 26, 2013
P3, N=27, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- cefepime hydrochloride / Generic mfg., doripenem / Generic mfg.
Trial termination: A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections (clinicaltrials.gov) - Oct 13, 2013
P3, N=41, Terminated, Sponsor: Janssen Research & Development, LLC
Active, not recruiting --> Completed Recruiting --> Terminated; Trial terminated early per business decision
- doripenem / Generic mfg., meropenem / Generic mfg.
Trial termination: A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections (clinicaltrials.gov) - Oct 13, 2013
P3, N=41, Terminated, Sponsor: Janssen Research & Development, LLC
Recruiting --> Terminated; Trial terminated early per business decision Recruiting --> Terminated; Trial terminated early per business decision
- cefepime hydrochloride / Generic mfg., doripenem / Generic mfg.
Enrollment change: A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia (clinicaltrials.gov) - Oct 13, 2013
P3, N=7, Terminated, Sponsor: Janssen Research & Development, LLC
Recruiting --> Terminated; Trial terminated early per business decision N=140 --> 7
- cefepime hydrochloride / Generic mfg., doripenem / Generic mfg.
Enrollment change: A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections (clinicaltrials.gov) - Oct 13, 2013
P3, N=41, Terminated, Sponsor: Janssen Research & Development, LLC
N=140 --> 7 N=140 --> 41
- doripenem / Generic mfg., meropenem / Generic mfg.
Enrollment change: A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections (clinicaltrials.gov) - Oct 13, 2013
P3, N=41, Terminated, Sponsor: Janssen Research & Development, LLC
N=140 --> 41 N=140 --> 41
- amoxycillin/clavulanate / Generic mfg.
Trial completion: Maxillary Sinus Irrigation in the Management of Chronic Rhinosinusitis (clinicaltrials.gov) - Oct 5, 2013
P=N/A, N=50, Completed, Sponsor: Ohad Ronen
N=140 --> 41 Recruiting --> Completed
- amoxycillin/clavulanate / Generic mfg.
Trial withdrawal, Adverse events: A Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate (clinicaltrials.gov) - Sep 22, 2013
P4, N=0, Withdrawn, Sponsor: Pfizer
Recruiting --> Completed Not yet recruiting --> Withdrawn
- amoxycillin/clavulanate / Generic mfg.
Enrollment change, Adverse events: A Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate (clinicaltrials.gov) - Sep 22, 2013
P4, N=0, Withdrawn, Sponsor: Pfizer
Not yet recruiting --> Withdrawn N=400 --> 0
- ||| amoxycillin/clavulanate / Generic mfg.
New P3 trial: Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis (clinicaltrials.gov) - Sep 2, 2013
P3, N=27, Completed, Sponsor: GlaxoSmithKline
- | amoxycillin/clavulanate / Generic mfg.
Trial completion: ABCAL: Place of Antibiotics in the Postoperative Acute Lithiasic Cholecystitis (clinicaltrials.gov) - Sep 1, 2013
P3, N=414, Completed, Sponsor: Centre Hospitalier Universitaire, Amiens
N=400 --> 0 Recruiting --> Completed
- cefepime hydrochloride / Generic mfg., doripenem / Generic mfg.
Trial termination: A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia (clinicaltrials.gov) - Aug 14, 2013
P3, N=7, Terminated, Sponsor: Janssen Research & Development, LLC
Recruiting --> Completed Suspended --> Terminated; Trial terminated early per business decision
- | amoxycillin/clavulanate / Generic mfg.
Enrollment change: MERAK: A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs (clinicaltrials.gov) - Jul 15, 2013
P3, N=16, Completed, Sponsor: Bayer
Suspended --> Terminated; Trial terminated early per business decision N=898 --> 16
- amoxycillin/clavulanate / Generic mfg.
Trial termination: Duration of Postoperative Antibiotic Prophylaxis in Facial Fractures (clinicaltrials.gov) - Jul 11, 2013
P4, N=217, Terminated, Sponsor: University Hospital Inselspital, Berne
N=898 --> 16 Recruiting --> Terminated; Limited number of patients
- amoxycillin/clavulanate / Generic mfg.
Enrollment closed: Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota (clinicaltrials.gov) - Mar 13, 2013
P=N/A, N=48, Active, not recruiting, Sponsor: Beth Israel Deaconess Medical Center
Recruiting --> Terminated; Limited number of patients Recruiting --> Active, not recruiting
- | amoxycillin/clavulanate / Generic mfg.
New P1 trial: Bioequivalence Study of an Amoxicillin-Clavulanic (clinicaltrials.gov) - Jan 17, 2013
P1, N=35, Completed, Sponsor: GlaxoSmithKline
- || ciprofloxacin oral / Generic mfg., amoxycillin/clavulanate / Generic mfg.
New P3 trial: A Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmo (clinicaltrials.gov) - Nov 25, 2012
P3, N=100, Terminated, Sponsor: Quanta Medical
- amoxycillin/clavulanate / Generic mfg.
Enrollment closed, HEOR, Cost effectiveness: DIABOLO: Diverticulitis: Antibiotics or Close Observation? (clinicaltrials.gov) - Oct 25, 2012
P4, N=533, Active, not recruiting, Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ciprofloxacin oral / Generic mfg., amoxycillin/clavulanate / Generic mfg.
Trial termination, Combination therapy, Monotherapy: Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (clinicaltrials.gov) - Sep 19, 2012
P=N/A, N=351, Terminated, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Recruiting --> Active, not recruiting Active, not recruiting --> Terminated; low accrual
- ciprofloxacin oral / Generic mfg., amoxycillin/clavulanate / Generic mfg.
Enrollment change, Combination therapy, Monotherapy: Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (clinicaltrials.gov) - Sep 19, 2012
P=N/A, N=351, Terminated, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Terminated; low accrual N=530 --> 351
- | amoxycillin/clavulanate / Generic mfg.
Trial completion: Amoxicillin-clavulanate in Treating Acute Otitis Media Evaluated by Daily Tympanometry (clinicaltrials.gov) - Jun 18, 2012
P3, N=84, Completed, Sponsor: University of Oulu
N=530 --> 351 Recruiting --> Completed
- || amoxycillin/clavulanate / Generic mfg.
New P2/3 trial, Metastases: PANTAP: Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia (clinicaltrials.gov) - May 13, 2012
P2/3, N=106, Recruiting, Sponsor: Radboud University
- amoxycillin/clavulanate / Generic mfg.
New P4 trial: Duration of Postoperative Antibiotic Prophylaxis in Facial Fractures (clinicaltrials.gov) - Apr 19, 2012
P4, N=217, Terminated, Sponsor: University Hospital Inselspital, Berne
- cefuroxime / Generic mfg., amoxycillin/clavulanate / Generic mfg.
Clinical: AMOCEF: Pharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care Units (clinicaltrials.gov) - Apr 17, 2012
P=N/A, N=60, Recruiting, Sponsor: University Hospital, Ghent
- New P4 trial: Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori (clinicaltrials.gov) - Apr 9, 2012
P4, N=208, Terminated, Sponsor: Buddhist Tzu Chi General Hospital